Skip to content

Delcath 系统

US · DCTH #3706 按市值排名
14.08 -0.73 -4.93%
实时 - 追踪5344个代码 - 心跳于141秒前 · 2026-10-16 19:47

✦ 量化股权信号 计算方式说明

减持
  • 机构持股总比例下降了1.1个百分点。

机构持股

机构持股比例
50.85% -1.05pp
机构数量
146
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund27.48%
Hedge Fund19.60%
Individual/Insider7.55%
Public Company3.12%
Private Company0.22%
Insurance Company0.19%
VC/PE Fund0.12%
Government Pension Fund0.12%
Other41.60%

主要股东 截至 2026-06-30

Rosalind Advisors, Inc. 9.51% · 3.30M 股
BlackRock 7.80% · 2.71M 股
Daniel Kaufman 5.09% · 1.77M 股
Vanguard Capital Management, LLC 4.04% · 1.40M 股
Propel Bio Management, LLC 2.51% · 871.46K 股
Geode Capital Management, LLC 2.11% · 733.12K 股
State Street Global Advisors 1.96% · 679.28K 股
Algert Global LLC 1.67% · 580.71K 股
Millennium Management LLC 1.63% · 566.37K 股
Divisadero Street Capital Management, LP 1.44% · 499.80K 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 48次买入 · 2次卖出

姓名职务持股比例
Gerard Michel Chief Executive Officer 0.99%
Vojislav Vukovic Chief Medical Officer 0.49%
David Hoffman General Counsel, Corporate Secretary & Chief Compliance Officer 0.25%
Steven Salamon Independent Director 0.24%
Sandra Pennell Senior VP of Finance and Principal Financial & Accounting Officer 0.22%
Gilad Aharon Independent Director 0.15%
Kevin Muir Former Vice President of Commercial Operations 0.07%
John Sylvester Independent Chairperson 0.04%
Martha Rook Chief Operating Officer 0.02%
Elizabeth Czerepak Independent Director --

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-05-12 Elizabeth Czerepak Independent Director Other Derivative Acquisition +22,500 $11.61
2026-05-12 Steven Salamon Independent Director Other Derivative Acquisition +22,500 $11.61
2026-05-12 John Sylvester Independent Chairperson Other Derivative Acquisition +22,500 $11.61
2026-05-12 Gilad Aharon Independent Director Other Derivative Acquisition +22,500 $11.61
2026-05-12 Bridget Martell Director Other Derivative Acquisition +22,500 $11.61
2026-03-05 Sandra Pennell Senior VP of Finance and Principal Financial & Accounting Officer Open Market Acquisition +5,533 $9.04
2026-03-01 Gerard Michel Chief Executive Officer Open Market Acquisition +11,200 $8.96
2026-02-16 Gerard Michel Chief Executive Officer Other Derivative Acquisition +97,500 --
2026-02-16 Gerard Michel Chief Executive Officer Other Derivative Acquisition +195,000 $9.40
2026-02-16 Vojislav Vukovic Chief Medical Officer Other Derivative Acquisition +28,250 --
2026-02-16 Vojislav Vukovic Chief Medical Officer Other Derivative Acquisition +56,500 $9.40
2026-02-16 Sandra Pennell Senior VP of Finance and Principal Financial & Accounting Officer Other Derivative Acquisition +28,250 --
2026-02-16 Sandra Pennell Senior VP of Finance and Principal Financial & Accounting Officer Other Derivative Acquisition +56,500 $9.40
2026-02-16 Martha Rook Chief Operating Officer Other Derivative Acquisition +28,250 --
2026-02-16 Martha Rook Chief Operating Officer Other Derivative Acquisition +56,500 $9.40
2026-02-16 David Hoffman General Counsel, Corporate Secretary & Chief Compliance Officer Other Derivative Acquisition +28,250 --
2026-02-16 David Hoffman General Counsel, Corporate Secretary & Chief Compliance Officer Other Derivative Acquisition +56,500 $9.40
2026-02-16 Kevin Muir Former Vice President of Commercial Operations Other Derivative Acquisition +28,250 --
2026-02-16 Kevin Muir Former Vice President of Commercial Operations Other Derivative Acquisition +56,500 $9.40
2025-11-20 John Sylvester Independent Chairperson Open Market Acquisition +4,386 $8.89

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:47:40 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

Delcath 系统 讨论区 0 条评论

发表评论